View more in
Health

Characteristics of expedited programmes for cancer drug approval in China

Nature.com
 2021-05-10

Tsinghua Clinical Research Institute, School of Medicine, Tsinghua University, Beijing, China. *These authors contributed equally. Tsinghua Clinical Research Institute, School of Medicine, Tsinghua University, Beijing, China. *These authors contributed equally. Cuicui Xie. Pharmcube (Beijing) Co., Ltd., Beijing, China. Qing Zhou. Guangdong Lung Cancer Institute, Guangdong Provincial People’s Hospital and Guangdong...

www.nature.com